argenx SE | ARGX - Cost Of Sales


argenx SE reported $145M in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
AstraZeneca USD 2.52B 2.73B Jun/2026
Genmab DKK 84M 19M Jun/2026
GlaxoSmithKline GBP 2.07B 192M Jun/2026
GRIFOLS EUR 1.17B 90M Jun/2026
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Lakefront Biotherapeutics EUR 4.8M 4.34M Mar/2026
Qiagen NV USD 196.45M 13.73M Jun/2026
UCB EUR 1.07B 146M Dec/2025